China economic policy for last decades were penetrating through global community economically and using multiple strategies to achieving a share from global market such as Dumping, Copying industrial design and patents.
Economic workers, Low prices and powerful industries made China one of the pioneer suppliers of Biotechnology products and pharmaceutical primary materials.
Novo Nordisk known as a pioneer biotech company in the global ranking, became one of the customers of other countries primary material. The thing that helped China understanding the needs of market and become one more powerful.
China Taiwan military conflict countdown started for 2022, The thing that is a big danger for chains of supply in the Europe and America. Novo Nordisk economical challenge with this war will be serious and soon may damage existence of FDA approved products in the global market.
The thing that is a big damage for stocks price and share holders. Novo Nordisk branding will face big challenge and this will lead to the decrease of penetrating rate through the market.
In other hands, price of products will increase and some products will enter to the luxury baskets and become luxury cure methods. It seems that Lars Fruergaard Jørgensen should be ready for a big economic recession in the company and choosing a new strategy for short term.
No comments:
Post a Comment